Richardson Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.8K Hold
535
0.04% 100
2026
Q1
$81.7K Hold
535
0.04% 96
2025
Q4
$73.8K Hold
535
0.04% 86
2025
Q3
$68.6K Buy
+535
New +$65.3K 0.03% 87

Other funds holding NVS

Richardson Capital Management's NVS Position: Q2 2026 in Review

Richardson Capital Management held its Novartis (NVS) position steady in Q2 2026 at 535 shares worth $83.8K. The position accounts for 0.04% of the portfolio, ranked #100.

Richardson Capital Management first reported a position in NVS in Q3 2025 and has held it in 4 quarters since. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Richardson Capital Management held 535 shares of Novartis worth $83.8K as of Q2 2026.
  • Richardson Capital Management left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.04% of Richardson Capital Management's portfolio in Q2 2026, its #100 holding.
  • Richardson Capital Management first reported a position in Novartis in Q3 2025 and has held it in 4 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Richardson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.